合理用药
不良反应
新药前沿
药物治疗
关键字:
搜索栏目:
 首页 >> 合理用药 >> 新药前沿
美国FDA批准血液稀化药物Brilinta治疗急性冠脉综合征
作者:网络来源 时间:2011-07-27 点击:346 来源:网络来源
<P style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 23.5pt; mso-pagination: widow-orphan; mso-line-height-alt: 0pt; mso-char-indent-count: 1.96"><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">美国</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">FDA</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">于</SPAN> <SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">7</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">月</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">20</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">日</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">批准血液化药物</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt" XML:LANG="EN-US">Brilinta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">(</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">ticagrelor</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">,</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">替卡格雷)用于急性冠脉综合征(</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">ACS</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">)患者,以减少心血管死亡和心脏病发作。</SPAN></P> <P style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 23.5pt; mso-pagination: widow-orphan; mso-line-height-alt: 0pt; mso-char-indent-count: 1.96"><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">ACS</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">包括如不稳定型心绞痛或心脏病发作等疾病的一组症候群,均由于进入心脏的血流量减少引起。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt" XML:LANG="EN-US">Brilinta</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt">通过</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">防止新的血液凝块形成奏效,从而维持体内血液流动,帮助减少心血管事件的风险。</SPAN></P> <P style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 23.5pt; mso-pagination: widow-orphan; mso-line-height-alt: 0pt; mso-char-indent-count: 1.96"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt">已对</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt" XML:LANG="EN-US">Brilinta</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-font-kerning: 0pt">与阿司匹林联用作了研究。本品标签的加框警示语提示医务人员和患者,当每日阿司匹林剂量超过</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial" XML:LANG="EN-US">100</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial">毫克,本品的疗效就会下降。</SPAN></P>
返回>>>
浙江省医院药事管理质控中心网 版权所有@2008 All Right Reserved。 浙江省医院药事管理质控中心主办
地址:杭州市庆春路79号(310003)        Email:zhejiangyszk@163.com
建议浏览器IE6.0+ 分辨率:1024*768以上